Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
Go back to Aprea Therapeutics Appoints John Hamill as Chief Financial Officer| Aperture Health, Inc. (NASDAQ: APRE) | Delayed: 0.68 +0.02 (3.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $0.08 | |||
| Open | $0.78 | 52 Week Low | $0.00 | |||
| Day High | $0.78 | P/E | N/A | |||
| Day Low | $0.66 | EPS | $0.00 | |||
| Volume | 28,224 | |||||

